live-attenuated Bordetella pertussis vaccine (BPZE1) / ILiAD Biotechnologies 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
live-attenuated Bordetella pertussis vaccine (BPZE1) / ILiAD Biotechnologies
CHAMPION-1, NCT05461131: Pertussis Challenge Study in Adults Vaccinated With BPZE1

Completed
2
53
Europe
BPZE1, Placebo, Azithromycin, Bordetella Pertussis Challenge Strain
ILiAD Biotechnologies
Pertussis/Whooping Cough, Bordetella Pertussis, Whooping Cough
07/23
10/23
NCT05116241: Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children

Active, not recruiting
2
360
Europe, RoW
BPZE1 pertussis vaccine and placebo, BPZE1 pertussis vaccine and Boostrix, Placebo and Boostrix
ILiAD Biotechnologies
Bordetella Pertussis, Whooping Cough
04/24
04/24

Download Options